Utah Medical Products, Inc. (NASDAQ:UTMD) has earned an average broker rating score of 0.00 () from the zero analysts that cover the company, Zacks Investment Research reports.
Zacks has also given Utah Medical Products an industry rank of 173 out of 265 based on the ratings given to related companies.
UTMD has been the subject of several analyst reports. BidaskClub lowered Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. ValuEngine upgraded Utah Medical Products from a “sell” rating to a “hold” rating in a research note on Tuesday, June 6th.
Utah Medical Products (NASDAQ UTMD) traded down 1.12% during mid-day trading on Friday, hitting $70.40. The stock had a trading volume of 8,551 shares. The firm’s 50-day moving average is $71.27 and its 200 day moving average is $65.99. Utah Medical Products has a 12 month low of $56.30 and a 12 month high of $75.00. The company has a market cap of $261.82 million, a price-to-earnings ratio of 20.19 and a beta of 0.74.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, October 3rd. Shareholders of record on Friday, September 15th will be paid a $0.265 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $1.06 dividend on an annualized basis and a yield of 1.51%. Utah Medical Products’s payout ratio is presently 30.37%.
A number of large investors have recently modified their holdings of the company. Acrospire Investment Management LLC raised its stake in shares of Utah Medical Products by 339.1% in the second quarter. Acrospire Investment Management LLC now owns 1,919 shares of the medical instruments supplier’s stock worth $139,000 after buying an additional 1,482 shares during the last quarter. Strs Ohio raised its stake in shares of Utah Medical Products by 8.0% in the second quarter. Strs Ohio now owns 2,700 shares of the medical instruments supplier’s stock worth $195,000 after buying an additional 200 shares during the last quarter. Everett Harris & Co. CA acquired a new stake in shares of Utah Medical Products during the second quarter worth about $210,000. Prudential Financial Inc. acquired a new stake in shares of Utah Medical Products during the second quarter worth about $233,000. Finally, The Manufacturers Life Insurance Company raised its stake in shares of Utah Medical Products by 15.4% in the second quarter. The Manufacturers Life Insurance Company now owns 3,355 shares of the medical instruments supplier’s stock worth $242,000 after buying an additional 448 shares during the last quarter. Institutional investors and hedge funds own 65.24% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Zacks: Utah Medical Products, Inc. (UTMD) Given Average Rating of “” by Analysts” was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://stocknewstimes.com/2017/08/23/zacks-utah-medical-products-inc-utmd-given-average-rating-of-by-analysts.html.
Utah Medical Products Company Profile
Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.
Get a free copy of the Zacks research report on Utah Medical Products (UTMD)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Utah Medical Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
